Home » Topics » BioWorld Science

BioWorld Science
RSS

Reistone Biopharma divulges new CatC inhibitors

June 30, 2022

Roche presents new EGFR mutant inhibitors

June 30, 2022

Eubulus Biotherapeutics discloses new GPX4 inhibitors

June 30, 2022

Sunshine Lake Pharma patents new GCGR and/or GLP-1 receptor agonists

June 30, 2022

ADAM10 may be a promising therapeutic target for AML

June 30, 2022

Myelin-forming cells change in multiple brain diseases

June 29, 2022

Scorpion selects Exon 20 mutant EGFR inhibitor STX-721 as development candidate

June 29, 2022

PDX models of radiation-resistant pediatric high-grade glioma show sensitivity to MAPK inhibition

June 29, 2022

miR-135b discriminates tongue cancer from noncancerous tissue

June 29, 2022

Series B financing at MiroBio funds development of checkpoint agonists to treat autoimmune diseases

June 29, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...